Serum Uric Acid Predicts Both Current and Future Components of the Metabolic Syndrome

Overview

Journal Metab Syndr Relat Disord

Date 2013 Jan 31

PMID 23360433

Citations 27

Authors

Kristy Osgood

Jonathan Krakoff

Marie Thearle

Affiliations

Soon will be listed here.

Abstract

Background: Uric acid (UA) is known to be associated with excess adiposity and insulin resistance. Our aim was to investigate the relationship between UA and the factors associated with the metabolic syndrome and type 2 diabetes mellitus (T2DM), both initially and longitudinally.

Methods: Serum UA was assessed as a potential determinant of concurrent blood pressure, serum lipids, glucose regulation measured via an oral glucose tolerance test (OGTT), acute insulin response (AIR), and insulin action (M) measured with hyperinsulinemic-euglycemic clamps in 245 participants (72% Native American, 56% male). UA was also assessed as a predictor of the above variables in 60 participants with follow-up data available (median follow-up time=11.2 years [interquartile range (IQR)=8.1, 13.6 years]. The impact of UA on the risk of T2DM was determined as 36 of the 245 participants developed T2DM after the baseline visit.

Results: UA was negatively associated with both concurrent and future M, such that for every 1 mg/dL increase in serum UA, M decreased 7.6% (P<0.001) and future M decreased 6.3% (P=0.02). However, UA was not associated with AIR (P=0.7). UA concentrations were a predictor of T2DM [hazard risk ratio (HRR)=1.5; P=0.02]. UA was positively associated with both concurrent blood pressure and lipids and also predicted future increases in blood pressure and total cholesterol.

Conclusions: Not only did UA associate with concomitant insulin action, blood pressure, and lipids, it also predicted future declines in insulin action and T2DM. UA is a potential target for preventing decreases in insulin sensitivity and rises in blood pressure and cholesterol.

Citing Articles

Urate Levels as a Predictor of the Prevalence and Level of Cardiovascular Risk Factors: An Identificación de La PoBlación Española de Riesgo Cardiovascular y Renal Study.

Antelo-Pais P, Prieto-Diaz M, Mico-Perez R, Pallares-Carratala V, Velilla-Zancada S, Polo-Garcia J Biomolecules. 2025; 14(12.

PMID: 39766237 PMC: 11673880. DOI: 10.3390/biom14121530.

The Association between Uric Acid and Metabolic Syndrome in a Middle-Aged and Elderly Taiwanese Population: A Community-Based Cross-Sectional Study.

Lin C, Tsai P, Wang C, Chen J Healthcare (Basel). 2024; 12(1).

PMID: 38201018 PMC: 10778807. DOI: 10.3390/healthcare12010113.

Gender difference in the association between gout at diagnosis and metabolic syndrome in African population: a retrospective cohort study.

Lekpa F, Same Bebey F, Bouallo I, Njonnou S, Namme Luma H, Singwe-Ngandeu M Pan Afr Med J. 2023; 43:164.

PMID: 36825121 PMC: 9941612. DOI: 10.11604/pamj.2022.43.164.37197.

The Impact of Obesity Surgery on Serum Uric Acid in People With Severe Obesity: A Retrospective Study.

Vafa L, Amini M, Kamran H, Aghakhani L, Hosseini S, Mohammadi Z Clin Nutr Res. 2023; 12(1):21-28.

PMID: 36793775 PMC: 9900075. DOI: 10.7762/cnr.2023.12.1.21.

Uric acid relationships with lipid profile and adiposity indices: Impact of different hyperuricemic thresholds.

Maloberti A, Vanoli J, Finotto A, Bombelli M, Facchetti R, Redon P J Clin Hypertens (Greenwich). 2022; 25(1):78-85.

PMID: 36573350 PMC: 9832232. DOI: 10.1111/jch.14613.

References

Lillioja S, Bogardus C . Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev. 1988; 4(5):517-40. DOI: 10.1002/dmr.5610040508. View

Yalow R, Berson S . Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960; 39:1157-75. PMC: 441860. DOI: 10.1172/JCI104130. View

Simental-Mendia L, Rodriguez-Moran M, Guerrero-Romero F . Failure of beta-cell function to compensate lack of insulin action in hyperuricemic subjects. Diabetes Metab Res Rev. 2009; 25(6):535-41. DOI: 10.1002/dmrr.988. View

Bonora E, Capaldo B, Cavallo Perin P, Del Prato S, De Mattia G, Frittitta L . Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis. 2007; 18(9):624-31. DOI: 10.1016/j.numecd.2007.05.002. View

Lillioja S, Nyomba B, Saad M, Ferraro R, Castillo C, BENNETT P . Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J Clin Endocrinol Metab. 1991; 73(4):866-76. DOI: 10.1210/jcem-73-4-866. View

Dehghan A, van Hoek M, Sijbrands E, Hofman A, Witteman J . High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2007; 31(2):361-2. DOI: 10.2337/dc07-1276. View

Catena C, Giacchetti G, Novello M, Colussi G, Cavarape A, Sechi L . Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens. 2003; 16(11 Pt 1):973-8. DOI: 10.1016/s0895-7061(03)01002-1. View

Scherrer U, Sartori C . Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol. 2000; 142(4):315-23. DOI: 10.1530/eje.0.1420315. View

Dogan A, Yarlioglues M, Gungor Kaya M, Karadag Z, Dogan S, Ardic I . Effect of long-term and high-dose allopurinol therapy on endothelial function in normotensive diabetic patients. Blood Press. 2010; 20(3):182-7. DOI: 10.3109/08037051.2010.538977. View

10.

Schwarzmeier J, Marktl W, Moser K, LUJF A . Fructose induced hyperuricemia. Effects of fructose on the de novo synthesis of adenine nucleotides in the liver and skeletal muscles of rats. Res Exp Med (Berl). 1974; 162(4):341-46. DOI: 10.1007/BF01851705. View

11.

Bunt J, Krakoff J, Ortega E, Knowler W, Bogardus C . Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations. Diabetes Metab Res Rev. 2006; 23(4):304-10. PMC: 2128254. DOI: 10.1002/dmrr.686. View

12.

Knowler W, Pettitt D, Savage P, BENNETT P . Diabetes incidence in Pima indians: contributions of obesity and parental diabetes. Am J Epidemiol. 1981; 113(2):144-56. DOI: 10.1093/oxfordjournals.aje.a113079. View

13.

Tataranni P, Ravussin E . Use of dual-energy X-ray absorptiometry in obese individuals. Am J Clin Nutr. 1995; 62(4):730-4. DOI: 10.1093/ajcn/62.4.730. View

14.

Bogardus C, Lillioja S, Howard B, Reaven G, Mott D . Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest. 1984; 74(4):1238-46. PMC: 425290. DOI: 10.1172/JCI111533. View

15.

Choi J, Ford E, Gao X, Choi H . Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2008; 59(1):109-16. DOI: 10.1002/art.23245. View

16.

Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K . Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol. 2003; 18(6):523-30. DOI: 10.1023/a:1024600905574. View

17.

Wong W, Wong S, Tian X, Huang Y . Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol. 2010; 55(4):300-7. DOI: 10.1097/fjc.0b013e3181d7671c. View

18.

Yoo T, Sung K, Shin H, Kim B, Kim B, Kang J . Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005; 69(8):928-33. DOI: 10.1253/circj.69.928. View

19.

Emmerson B . Effect of oral fructose on urate production. Ann Rheum Dis. 1974; 33(3):276-80. PMC: 1006256. DOI: 10.1136/ard.33.3.276. View

20.

Khosla U, Zharikov S, Finch J, Nakagawa T, Roncal C, Mu W . Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005; 67(5):1739-42. DOI: 10.1111/j.1523-1755.2005.00273.x. View